Latest Shareholder Value News

Neometals Ltd implements a significant 25% cut in cash personnel costs by reducing director and staff salaries, while introducing retention performance rights to key executives to maintain strategic momentum.

Venus Metals Corporation (ASX:VMC) has fortified its balance sheet with a $47 million sale of its Youanmi Gold Project royalty, rebuffed a hostile takeover, and set in motion significant shareholder returns including a $35 million cash dividend.

Yugo Metals is pushing ahead with exploration in Bosnia and Herzegovina, backed by a fresh $5 million capital raise and encouraging early gold results at its Sinjakovo Project. Preparations are underway for new drilling at Cajnice, while the company continues to expand its footprint in battery and base metals.

Iondrive Limited has independently confirmed strong rare earth recoveries from U.S. magnet waste and gained Oklahoma government support for its first commercial processing module, advancing its U.S. commercialisation strategy.

Riedel Resources has transformed into a multi-project gold explorer with the acquisition of controlling interests in the Cosmo and Mt Venn projects in Western Australia, complementing its Kingman asset in Arizona. The company is gearing up for maiden drilling and expanded exploration across its portfolio.

Ariana Resources has sold its remaining 9.9% stake in the Kiziltepe mine for US$3.7 million, boosting cash reserves to A$39 million and sharpening focus on its flagship 1.6Moz Dokwe Gold Project in Zimbabwe.

Spectur Limited posted its strongest quarter of cash receipts in FY26, driven by new contracts and a major technology upgrade, while launching legal action over significant customer losses.

Far East Gold has boosted its stake in the Idenburg Gold Project to 51%, revealing a 44% increase in inferred gold resources to 780,000 ounces. The company’s Independent Board Committee advises shareholders to reject an unsolicited takeover bid from Xingye Gold, which an expert deems undervalues the company.

Alterity Therapeutics has cleared a major regulatory hurdle with the FDA endorsing a single pivotal Phase 3 trial for its ATH434 drug in Multiple System Atrophy, setting the stage for trial initiation by the end of 2026.

Betr Entertainment reported its first positive operating cash flow since 2021 with $2.6 million in Q4 FY26, driven by improved customer engagement and promotional efficiency. The company enters FY27 with strong momentum, including over 15% turnover growth in July excluding World Cup effects and record Same Game Multi volumes.

Lightning Minerals has executed a strategic reset focusing on Australian gold and critical minerals, securing $1.85 million to accelerate exploration at its flagship Mt Turner and Warby Tungsten projects. Key technical milestones include an independent petrology study validating Mt Turner's gold system and promising tungsten assay results at Warby.

Titan Minerals has ramped up drilling at its Dynasty Gold Project, confirming extensions to mineralisation and advancing scoping studies ahead of a resource upgrade targeted for early 2027.